$6.16
-0.08 (-1.28%)
Open$6.24
Previous Close$6.24
Day High$6.33
Day Low$6.06
52W High$23.20
52W Low$3.51
Volume—
Avg Volume5.72M
Market Cap665.00M
P/E Ratio—
EPS$-1.95
SectorPharmaceuticals
Analyst Ratings
Hold
17 analysts
Price Target
+587.0% upside
Current
$6.16
$6.16
Target
$42.32
$42.32
$27.22
$42.32 avg
$56.32
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 99.59M | 91.08M | 180.40M |
| Net Income | -265,146,939 | -218,247,891 | 49.45M |
| Profit Margin | -266.3% | -252.9% | 27.4% |
| EBITDA | -262,663,987 | -228,215,463 | 94.91M |
| Free Cash Flow | — | — | 60.57M |
| Rev Growth | +9.3% | +9.3% | -1.4% |
| Debt/Equity | 0.20 | 0.20 | 0.60 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |